Methylbutyltryptamine

(Redirected from MBT (drug))

MBT, or N-methyl-N-butyltryptamine, is a lesser-known psychedelic drug. MBT was first synthesized by Alexander Shulgin. In his book TiHKAL (Tryptamines I Have Known and Loved), the minimum dosage is listed as 250-400 mg, and the duration listed as 4–6 hours. MBT produces a heavy body load with dehydration, and causes visuals similar to those of DMT. Very little data exists about the pharmacological properties, metabolism, and toxicity of MBT.

Methylbutyltryptamine
Identifiers
  • N-[2-(1H-indol-3-yl)ethyl]-N-methylbutan-1-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC15H22N2
Molar mass230.355 g·mol−1
3D model (JSmol)
  • CCCCN(C)CCC1=CNC2=CC=CC=C21
  • InChI=1S/C15H22N2/c1-3-4-10-17(2)11-9-13-12-16-15-8-6-5-7-14(13)15/h5-8,12,16H,3-4,9-11H2,1-2H3
  • Key:PUEYINPKMCBJCA-UHFFFAOYSA-N

MSBT

edit

TiHKAL mentions that a structural isomer of MBT exists, with the butyl group attached at the nitrogen atom. It is known as N-s-butyl-N-methyltryptamine, or MSBT. However, little is known about its psychoactivity.

See also

edit
edit